Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
Clinical trial NCT02997228 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02997228
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-19
- Primary completion
- 2027-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.